Signaling Pathways - eIF4E/eIF3G interaction - Histone Acetyltransferases (HATs) - HDAC - CSF-1R
清除全部
-
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 酪氨酸激酶抑制剂(TKI) -
B5916 Chidamide1 CitationTarget: HDACSummary: HDAC抑制剂 -
B4899 BLZ9451 CitationTarget: CSF-1RSummary: CSF-1R激酶抑制剂 -
B3696 4EGI-12 CitationTarget: eIF4E/eIF3G interactionSummary: 竞争性的eIF4E/eIF4G相互作用抑制剂。 -
A1655 GW25801 CitationTarget: CSF-1RSummary: CFMS激酶/CSF-1R抑制剂 -
A4492 NU 9056Target: Histone Acetyltransferases (HATs)Summary: KAT5（Tip60）HAT抑制剂 -
A4488 Anacardic acid中文名: 漆树酸Target: Histone Acetyltransferases (HATs)Summary: HAT抑制剂 -
A3761 RG2833Target: HDACSummary: 脑渗透性HDAC抑制剂 -
A3335 Curcumin1 Citation中文名: 姜黄素Target: Histone Deacetylases (HDACs)|Nrf2|Histone Acetyltransferases (HATs)|TyrosinasesSummary: Tyrosinase（酪氨酸酶）抑制剂 -
A3022 Pazopanib (GW-786034)中文名: 帕唑帕尼Target: CSF-1R|VEGFR|PDGFR|c-Kit|FGFRSummary: (GW-786034)VEGFR/PDGFR/FGFR 的抑制剂。